Taipei, Taiwan

Pao-Nien Chen

This inventor holds 3 USPTO granted patents. Top assignee: Development Center for Biotechnology. Active years: 2001-2014.


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 21(Granted Patents)


Location History:

  • Taipei, TW (2001)
  • Shi Chi, TW (2011)
  • New Taipei City, TW (2014)

Company Filing History:


Years Active: 2001-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Pao-Nien Chen: Innovator in Pharmaceutical Development

Introduction

Pao-Nien Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of 3 patents to his name, Chen's work focuses on innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Chen has developed quinazoline compounds as kinase inhibitors. This compound is designed for treating protein kinase-related diseases or disorders, featuring a complex structure that allows for targeted therapeutic effects. Additionally, he has created an aqueous inhalation pharmaceutical composition that comprises a polypeptide or protein. This composition aims to improve the bioavailability of the polypeptide and protein while minimizing toxicity in the lungs.

Career Highlights

Pao-Nien Chen is currently affiliated with the Development Center for Biotechnology. His work at this institution has been pivotal in advancing research and development in the pharmaceutical sector. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Chen has collaborated with esteemed colleagues, including Fan-Jung Liu and Chuan-Ming Lai. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research efforts.

Conclusion

Pao-Nien Chen's contributions to biotechnology and pharmaceutical development are noteworthy. His innovative patents and collaborative spirit continue to drive advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…